Impact of the COVID-19 Pandemic on the Outcomes of Patients Undergoing Oncological Surgeries: CORONAL Study
CONCLUSIONS: Surgical oncology patients who underwent postoperative care in the intensive care unit during the COVID-19 pandemic had higher hazard of 28-day mortality. Furthermore, these patients had higher odds of respiratory complications and pulmonary infections. Trials registration The study is registered in the Brazilian Registry of Clinical Trials under the code RBR-8ygjpqm, UTN code U1111-1293-5414.PMID:38530529 | DOI:10.1245/s10434-024-15152-9
Source: Ann Oncol - Category: Cancer & Oncology Authors: Felipe Souza Lima Vianna Laura Leonardi Neves Renato Testa Ant ônio Paulo Nassar Jo ão Henrique Ferdinando Peres Rafael Ávila Justino da Silva Fernanda de Paula Sales Dante Raglione Bruno Del Bianco Madureira Luiz Dalfior Luiz Marcelo S á Malbouisson Source Type: research
More News: Brazil Health | Cancer & Oncology | Clinical Trials | Coronavirus | COVID-19 | Intensive Care | Organic | Pandemics | Respiratory Medicine | Study